Niki BioSolutions, Inc. Restricted Cash and Cash Equivalents
Niki BioSolutions, Inc. (NIKI) had Restricted Cash and Cash Equivalents of $14.10 million as of 2018-12-31, per its 20-F filed 2019-04-15.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2019-04-15
- 2018-12-31: Restricted Cash and Cash Equivalents $14.10M.
- 2017-12-31: Restricted Cash and Cash Equivalents $480.00K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2018-12-31 | $14.10M 20-F · filed 2019-04-15 |
| 2017-12-31 | $480.00K 20-F · filed 2019-04-15 |